Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 1,000 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Daniel Trencher sold 1,000 shares of the company’s stock in a transaction on Wednesday, April 17th. The stock was sold at an average price of $13.21, for a total transaction of $13,210.00. Following the transaction, the insider now directly owns 26,192 shares in the company, valued at $345,996.32. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Daniel Trencher also recently made the following trade(s):

• On Monday, March 18th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The shares were sold at an average price of $15.18, for a total transaction of $15,180.00.
• On Monday, March 4th, Daniel Trencher sold 6,780 shares of Teladoc Health stock. The shares were sold at an average price of $14.52, for a total transaction of $98,445.60.
• On Tuesday, February 20th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The shares were sold at an average price of $20.64, for a total transaction of $20,640.00.

Teladoc Health Price Performance

Shares of TDOC stock opened at $12.99 on Friday. Teladoc Health, Inc. has a 1-year low of $12.85 and a 1-year high of $30.41. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The firm’s 50-day simple moving average is $15.59 and its 200-day simple moving average is $17.91.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.05. The business had revenue of $660.50 million for the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company’s revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.23) EPS. As a group, research analysts anticipate that Teladoc Health, Inc. will post -1.07 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Granite Bay Wealth Management LLC purchased a new position in Teladoc Health in the third quarter valued at approximately $3,675,000. Sowell Financial Services LLC raised its holdings in Teladoc Health by 40.8% in the fourth quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock valued at $407,000 after buying an additional 5,475 shares during the period. Lecap Asset Management Ltd. purchased a new position in Teladoc Health in the fourth quarter valued at approximately $1,530,000. Deutsche Bank AG raised its holdings in Teladoc Health by 12.4% in the third quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock valued at $5,598,000 after buying an additional 33,287 shares during the period. Finally, Sherbrooke Park Advisers LLC purchased a new position in Teladoc Health in the third quarter valued at approximately $680,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of research reports. DA Davidson lowered their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Canaccord Genuity Group lowered their price objective on shares of Teladoc Health from $34.00 to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, February 21st. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 target price on the stock. Citigroup reduced their target price on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Finally, Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Friday, April 5th. Eight equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $22.23.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.